%0 Journal Article
%T 广泛期小细胞肺癌联合免疫治疗的临床进展<br>Recent Clinical Advancements in the Combined Immunotherapy for Extensive-Stage Small Cell Lung Cancer
%A 陈红
%A 崔金霞
%J Asian Case Reports in Emergency Medicine
%P 49-57
%@ 2328-0395
%D 2024
%I Hans Publishing
%R 10.12677/acrem.2024.122007
%X 广泛期小细胞肺癌传统的一线治疗方案主要包括化疗和放疗，但往往存在耐药性和毒副作用的问题。免疫治疗作为一种新型的治疗策略，可以激活患者自身的免疫系统来攻击肿瘤细胞，具有更好的耐受性和长期效应。本综述主要介绍了广泛期小细胞肺癌传统治疗的局限性和免疫治疗的机制以及现阶段联合免疫治疗的临床进展。<br />
The traditional first-line treatment for extensive-stage small cell lung cancer mainly includes chemotherapy and radiotherapy, but there are often problems of drug resistance and toxic side effects. Immunotherapy, as a new type of treatment strategy, can activate the patient’s own immune system to attack tumor cells and has better tolerance and long-term effects. This review mainly introduces the limitations of traditional treatment for extensive-stage small cell lung cancer, the mechanism of immunotherapy, and the current clinical progress of combined immunotherapy.
%K 广泛期小细胞肺癌，免疫治疗，免疫联合治疗<br>Extensive-Stage Small Cell Lung Cancer
%K Immunotherapy
%K Combined Immunotherapy
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=83442